These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12009710)

  • 1. ARTS I -- the rapamycin eluting stent; ARTS II -- the rosy prophecy.
    Serruys PW
    Eur Heart J; 2002 May; 23(10):757-9. PubMed ID: 12009710
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus-eluting stent implantation in a heart transplant recipient.
    Tomai F; Gagliardi G; Proietti I
    Ital Heart J; 2004 May; 5(5):408-9. PubMed ID: 15185909
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting.
    Colombo A
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):61-2. PubMed ID: 15343569
    [No Abstract]   [Full Text] [Related]  

  • 4. No delayed restenosis at 18 months after implantation of sirolimus-eluting stent.
    Tanabe K; Degertekin M; Regar E; Ligthart JM; van der Giessen WJ; Serruys PW
    Catheter Cardiovasc Interv; 2002 Sep; 57(1):65-8. PubMed ID: 12203931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
    Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW
    Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
    Aziz S; Ramsdale DR
    J Invasive Cardiol; 2005 Jan; 17(1):13. PubMed ID: 15640532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience.
    Arampatzis CA; Hoye A; Lemos PA; Saia F; Tanabe K; Degertekin M; Sianos G; Smits PC; van der Giessen WJ; McFadden E; van Domburg R; de Feyter P; Serruys PW
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):57-60. PubMed ID: 15343568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overstretching undersized drug-eluting stents: a temporary solution.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):461-2. PubMed ID: 15065138
    [No Abstract]   [Full Text] [Related]  

  • 12. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
    Perin EC
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents for the prevention of restenosis: Standing the test of time.
    Carter AJ
    Catheter Cardiovasc Interv; 2002 Sep; 57(1):69-71. PubMed ID: 12203932
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of drug-eluting stents.
    Williams DO; Kereiakes DJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus-eluting stents. (The results of the five-year use for the treatment of coronary artery disease).
    Krylov AL
    Angiol Sosud Khir; 2006; 12(4):71-82. PubMed ID: 17679960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
    Vijayakumar M; Rodriguez Granillo GA; Lemos PA; Aoki J; Hoye A; Ong AT; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW
    J Invasive Cardiol; 2005 Jan; 17(1):10-2. PubMed ID: 15640531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment for clogged coronary arteries.
    Mayo Clin Health Lett; 2002 Dec; 20(12):4. PubMed ID: 12526107
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.